Post-polypectomy surveillance: follow-up recommendations from the Alberta Colorectal Cancer Screening Program

Daniel C Sadowski, M. Kolber, Anthony Gomes, Linda Hickle, R. Hilsden, David Ross McLean, Dereck Mok, B. Moysey, Nicole Nemecek, John David Ryan, R. Sultanian, Jessica Wiseman, Huiming Yang
{"title":"Post-polypectomy surveillance: follow-up recommendations from the Alberta Colorectal Cancer Screening Program","authors":"Daniel C Sadowski, M. Kolber, Anthony Gomes, Linda Hickle, R. Hilsden, David Ross McLean, Dereck Mok, B. Moysey, Nicole Nemecek, John David Ryan, R. Sultanian, Jessica Wiseman, Huiming Yang","doi":"10.1093/jcag/gwae007","DOIUrl":null,"url":null,"abstract":"\n In 2013, the Alberta Colorectal Cancer Screening Program (ACRCSP) initially published recommendations for post-colonoscopy follow-up and polypectomy. Over time, emerging evidence and evolving surveillance guidelines from various expert groups necessitated a comprehensive review to align with the healthcare landscape in Alberta. To accomplish this, an expert panel was convened. Using the Agree II tool, we identified high-quality Clinical Practice Guidelines that were relevant to the Alberta medical context. Recommendations from these guidelines were adapted to fit the specific needs of Alberta. Recognizing inconsistencies and gaps within the existing guidelines, we conducted targeted literature reviews to ensure a comprehensive and evidence-based approach to our recommendations.\n Our revised recommendations build upon the assumption that a high-quality index colonoscopy has been performed at baseline. They are intended to enhance the quality of care and reduce unnecessary procedures. As well, they align with the growing consensus in the scientific literature that individuals with low-risk tubular adenomas may not require aggressive colonoscopy surveillance.\n The updated Alberta recommendations aim to provide clear recommendations for practicing endoscopists, referring physicians, and their patients. They address crucial questions such as determining which patients should commence surveillance via colonoscopy and which individuals should return to average-risk screening using the fecal immunochemical test (FIT). Additionally, our recommendations outline the appropriate surveillance intervals for those requiring continued monitoring.","PeriodicalId":17263,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":" 23","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Canadian Association of Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jcag/gwae007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In 2013, the Alberta Colorectal Cancer Screening Program (ACRCSP) initially published recommendations for post-colonoscopy follow-up and polypectomy. Over time, emerging evidence and evolving surveillance guidelines from various expert groups necessitated a comprehensive review to align with the healthcare landscape in Alberta. To accomplish this, an expert panel was convened. Using the Agree II tool, we identified high-quality Clinical Practice Guidelines that were relevant to the Alberta medical context. Recommendations from these guidelines were adapted to fit the specific needs of Alberta. Recognizing inconsistencies and gaps within the existing guidelines, we conducted targeted literature reviews to ensure a comprehensive and evidence-based approach to our recommendations. Our revised recommendations build upon the assumption that a high-quality index colonoscopy has been performed at baseline. They are intended to enhance the quality of care and reduce unnecessary procedures. As well, they align with the growing consensus in the scientific literature that individuals with low-risk tubular adenomas may not require aggressive colonoscopy surveillance. The updated Alberta recommendations aim to provide clear recommendations for practicing endoscopists, referring physicians, and their patients. They address crucial questions such as determining which patients should commence surveillance via colonoscopy and which individuals should return to average-risk screening using the fecal immunochemical test (FIT). Additionally, our recommendations outline the appropriate surveillance intervals for those requiring continued monitoring.
息肉切除术后监测:艾伯塔省结直肠癌筛查计划的后续建议
2013 年,艾伯塔省结直肠癌筛查计划(ACRCSP)首次发布了关于结肠镜检查后随访和息肉切除术的建议。随着时间的推移,来自不同专家组的新证据和不断变化的监测指南要求进行全面审查,以符合艾伯塔省的医疗保健状况。为此,我们召集了一个专家小组。利用 Agree II 工具,我们确定了与艾伯塔省医疗环境相关的高质量临床实践指南。我们对这些指南中的建议进行了调整,以适应艾伯塔省的具体需求。认识到现有指南中存在的不一致和空白,我们进行了有针对性的文献回顾,以确保我们的建议采用全面的循证方法。我们修订后的建议建立在基线时已进行了高质量的索引结肠镜检查这一假设之上。这些建议旨在提高医疗质量,减少不必要的手术。此外,它们还与科学文献中日益增长的共识相一致,即低风险管状腺瘤患者可能不需要积极的结肠镜监测。更新后的艾伯塔建议旨在为执业内镜医师、转诊医师及其患者提供明确的建议。这些建议解决了一些关键问题,例如确定哪些患者应该开始通过结肠镜进行监控,哪些患者应该恢复使用粪便免疫化学检验 (FIT) 进行平均风险筛查。此外,我们的建议还概述了需要继续监测的患者的适当监测间隔。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
296
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信